By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Innovus Pharma 

4275 Executive Square
Suite 200
La Jolla  California  92037  U.S.A.
Phone: 858-964-5123 Fax: 858-964-2301



Company News
Innovus Pharma Announces Receipt Of Notice Of Intention To Grant Sensum+ European Patent 3/27/2017 6:26:25 AM
Innovus Pharma Announces The Cash Redemption Of All Outstanding Convertible Notes 3/22/2017 6:34:43 AM
Innovus Pharma Announces $3.85 Million Public Offering 3/16/2017 6:39:48 AM
Innovus Pharma Announces Receipt Of Notification To Commercialize Sensum+ In The European Union 3/8/2017 7:23:45 AM
Innovus Pharma Reports Record Annual Revenues For The Full Year 2016 Of $4.8 Million 3/7/2017 6:50:23 AM
Innovus Pharma Announces Receipt Of Notification To Commercialize Zestra In The European Union 3/2/2017 6:29:17 AM
Innovus Pharma Announces The Approval To Commercialize Zestra In South Korea Through Its Partner J&H Co. LTD 2/3/2017 7:59:00 AM
Innovus Pharma Expands Its Executive Management Team With The Addition Of Randy Berholtz As Its Executive Vice President, Corporate Development And General Counsel 1/9/2017 11:34:05 AM
Innovus Pharma Strengthens Its Respiratory Franchise With The In-Licensing Of Lertal Tablets, A Clinically Proven Supplement For The Relief Of Allergic Rhinitis Symptoms From NTC For The United States And Canada 12/19/2016 10:14:31 AM
Innovus Pharma Launches Its Clinically Proven Urivarx Product For Bladder Health Through Its Beyond Human Sales And Marketing Platform In The United States 12/1/2016 9:02:18 AM